News

The company will be responsible for manufacturing and supply of an injectable anesthetic agent. JHP president and CEO Stuart Hinchen said the company successfully completed an FDA (CBER)

Levetiracetam oral solution is used to treat partial onset seizures in people 16 years of age and older with epilepsy. The company expects to launch the product by

FluMist Quadrivalent contains four strains (two type A strains and two type B lineages) to help provide broad protection against circulating influenza A and B. The quadrivalent vaccine

As per the agreement, Abbott will make an initial upfront payment of $150m for rights related to the global collaboration. Upon successful completion of the RA Phase II

Lexapro tablets are used for acute and maintenance treatment of major depressive disorder (MDD) and acute treatment of generalized anxiety disorder (GAD). Mylan will sell the product exclusively

Avonex Pen (Avonex 30mcg/0.5mL solution for injection) is the first single-use, once-a-week, fully integrated intramuscular (IM)autoinjector, designed to be easier to use than currently available Avonex prefilled syringe.

The University of California San Francisco has received Investigational Review Board (IRB) approval. The single-arm, open-label and multi-center study will enroll up to 25 patients with stage III

ET-101 is a novel therapeutic antibody, currently under investigation for the inhibition of the growth of cancer stem cells. Under the deal, Lonza will produce phase 1 clinical

The company is expected to initiate a Phase I trial with mibefradil in normal healthy volunteers on 2 March 2012. The company will also initiate Phase Ib trial